BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
BioCorRx's operating income for the twelve months ending Jun 30, 2026 was -$4.90M. For fiscal 2025 it was -$4.83M. The highest annual figure on record is -$2.18M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.83M | – |
| FY2024 | Dec 31, 2024 | -$5.12M | – |
| FY2023 | Dec 31, 2023 | -$3.79M | – |
| FY2022 | Dec 31, 2022 | -$4.70M | – |
| FY2021 | Dec 31, 2021 | -$5.51M | – |
| FY2020 | Dec 31, 2020 | -$7.49M | – |
| FY2019 | Dec 31, 2019 | -$5.56M | – |
| FY2018 | Dec 31, 2018 | -$4.63M | – |
| FY2017 | Dec 31, 2017 | -$2.89M | – |
| FY2016 | Dec 31, 2016 | -$2.18M | – |
| FY2015 | Dec 31, 2015 | -$5.12M | – |
| FY2014 | Dec 31, 2014 | -$3.05M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.47M | – |
| Q1 FY2026 | Mar 31, 2026 | -$956.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$534.19K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.95M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.41M | – |
| Q1 FY2025 | Mar 31, 2025 | -$937.95K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.12M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.37M | – |
| Q1 FY2024 | Mar 31, 2024 | -$968.69K | – |
| Q4 FY2023 | Dec 31, 2023 | -$822.71K | – |
| Q3 FY2023 | Sep 30, 2023 | -$961.87K | – |
| Q2 FY2023 | Jun 30, 2023 | -$946.90K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.06M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.12M | – |
| Q2 FY2021 | Sep 30, 2021 | -$2.60M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.58M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.77M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.05M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.15M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.52M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.60M | – |
| Q3 FY2019 | Sep 30, 2019 | -$885.64K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.60M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.48M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.94M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.40M | – |
| Q2 FY2018 | Jun 30, 2018 | -$741.46K | – |
| Q1 FY2018 | Mar 31, 2018 | -$538.96K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.03M | – |
| Q3 FY2017 | Sep 30, 2017 | -$663.65K | – |
| Q2 FY2017 | Jun 30, 2017 | -$786.62K | – |
| Q1 FY2017 | Mar 31, 2017 | -$412.34K | – |
| Q4 FY2016 | Dec 31, 2016 | -$917.71K | – |
| Q3 FY2016 | Sep 30, 2016 | -$517.37K | – |
| Q2 FY2016 | Jun 30, 2016 | -$412.29K | – |
| Q1 FY2016 | Mar 31, 2016 | -$334.66K | – |
| Q4 FY2015 | Dec 31, 2015 | -$696.15K | – |
See a number that looks wrong?